Medicines And Healthcare Products Regulatory Agency
January 2026
MHRA strengthening dependency and addiction warnings on medicines used to t…
Professor Sir Aziz Sheikh: Towards next-generation pharmacovigilance capabi…
Nirogacestat hydrobromide approved to treat desmoid tumours
MHRA welcomes Professor Jacob George as he starts Chief Medical and Scienti…
MHRA approves zapomeran (Kostaive) mRNA COVID-19 vaccine
December 2025
MHRA urges public to avoid illegal online weight-loss medicines this New Ye…
Keep the warmth, lose the risk: MHRA and National Fire Chiefs Council issue…
How medicines affect gut bacteria could inform safer, more effective use
Healthcare regulator suggests simple winter wellness choices to keep you sa…
MHRA approves lenacapavir for the prevention of sexually transmitted HIV-1 …
MHRA seeks input on AI regulation at ‘pivotal moment’ for healthcare
MHRA updates guidance on the Health Institution Exemption to support safe u…
Professor Bola Owolabi CBE: Creating the Climate for Health Equity
UK approves the first twice yearly biological medicine for asthma and sever…
European first as MHRA approves over-the-counter allergy treatment for adol…
Festive foods and your medicines: MHRA shares advice to help you stay safe …
MHRA welcomes Professor Jonathan?Benger CBE as new CEO of NICE
UK and Singapore launch a regulatory innovation corridor to speed up access…
MHRA Chair welcomes re-appointment of three non-executive directors
Mirdametinib approved to treat plexiform neurofibromas in children, adolesc…
Strengthening collaboration between the MHRA and the Department of Health N…
Five festive mistakes you didn’t know you were making: MHRA urges the p…
Hepatitis B vaccines for babies
Chris Kessler: How access to innovative rare therapies can transform the li…
MHRA approves tisotumab vedotin for the treatment of cervical cancer
Patient and family experiences inform antidepressant safety information rev…
From Brussels sprouts to mobility scooters: five tips from the MHRA for sta…
November 2025
New MHRA-supported research reveals patterns of vaccine-derived poliovirus …
MHRA and NICE receive £2 million from Wellcome to improve safety and effect…
MHRA approves inavolisib for the treatment of breast cancer
Three convicted in major MHRA investigation into illegal online supply of m…
MHRA reaffirms safety of childhood vaccination
Professor Alastair Denniston: The future regulation of AI in healthcare
MHRA-led study reveals major inconsistencies in global microbiome research
Dr Alison Cave: Pharmacists are on the frontline of medicines safety – and …
MHRA approves Siiltibcy as a diagnostic aid for Mycobacterium tuberculosis …
MHRA appoints first Chief Medical and Scientific Officer
Professor Henrietta Hughes: Putting Patient Safety at the Heart of Regulato…
MHRA calls on public to report side effects and suspected fakes during #Med…
Major change for rare disease treatments on way, signals MHRA
October 2025
Concizumab approved to prevent or reduce the frequency of bleeding episodes…
MHRA smashes major?illicit?weight loss medicine production facility in reco…
Side effects from drug interactions to be predicted by AI before reaching p…
AI tools that could detect diseases earlier selected for next phase of MHRA…
Professor James Levine: When policy becomes medicine
The new Innovative Licensing and Access Pathway welcomes first investigatio…
100 years of protecting patients through biological standards for medicines
Dr Nicola Rose: A new antibiotic is positive news – but it will take more t…
MHRA and NICE invite early adopters to trial accelerated aligned pathway – …
Patients to benefit as UK and US regulators forge new collaboration on medi…
UK clinical trial approval times twice as fast with AI and reforms
MHRA patient safety essay competition 2025
Sir David Spiegelhalter: Regulation in an age of personalised medicine
September 2025
MHRA crackdown on illegal ‘Botox’ after victims left seriously ill
MHRA and partners unite to reaffirm prescription weight-loss medicine adver…
New Commission to help accelerate NHS use of AI
MHRA confirms taking paracetamol during pregnancy remains safe and there is…
Professor Richard FitzGerald appointed to the Commission on Human Medicines
MHRA and Department for Education embed medicine safety into school curricu…
Looking to our future: reflections on the strategic choices ahead for the M…
Vorasidenib approved to treat patients 12 years and older with grade 2 astr…
Increased risks identified with Profemur cobalt chrome modular neck hip rep…
August 2025
MHRA approves UK’s first new type of antibiotic for urinary tract infection…
MHRA approves zuranolone to treat postnatal depression in adults following …
MHRA launches Route B notification pilot as part of clinical trials regulat…
Parents and caregivers advised to stop all use of specific brand of kids’ m…
MHRA approves teplizumab to delay progression of type 1 diabetes
MHRA designated as WHO-Listed Authority: a milestone for UK life sciences a…
New review highlights untapped potential of the vaginal microbiome in women…
Patients will receive medicines 3-6 months faster under 10-Year Health Plan…
MHRA MedRegs blog – Summer 2025
MHRA begins recruitment for new digital roles at Leeds hub to drive innovat…
July 2025
MHRA outlines intent to speed up patient access to innovative medical devic…
Mirvetuximab soravtansine approved to treat adult patients who have ovarian…
Tofersen approved by the MHRA to treat rare inherited form of motor neurone…
Yellow Card centre launched in Northern Ireland to strengthen patient safet…
Summer ready: MHRA issues updated guidance on medicines and medical devices…
Cutting-edge personalised treatments, made while you wait, will deliver spe…
MHRA announces proposals to improve access to world’s best medical devices …
The MHRA and the global flu vaccine: How the UK is helping shape the world’…
MHRA’s 2024–25 Annual Report and Accounts and Impact Report show progress o…
MHRA approves adrenaline nasal spray - the first needle-free emergency trea…
Five non-executive directors reappointed to the Medicines and Healthcare pr…
MHRA CEO Lawrence Tallon welcomes Life Sciences Sector Plan
MHRA approves sebetralstat (Ekterly) to treat hereditary angioedema (HAE) a…
Government to align with European specifications on high risk in vitro diag…
Don’t let the heatwave affect your medicines: Three important tips from the…
MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms (…
MHRA approves nogapendekin alfa inbakicept to treat adult patients with non…
June 2025
AI Airlock, CERSIs and a new global AI network for health regulators
If you take a GLP-1 medicine and have been hospitalised by acute pancreatit…
MHRA seizes 7.7 million doses of illegal medicines and removes hundreds of …
MHRA publishes final Business Plan for 2023-2026 Corporate Plan
UK MHRA leads safe use of AI in healthcare as first country in new global n…
AI breakthroughs drive expansion of ‘Airlock’ testing programme to support …
MHRA approves UK’s first anti-PD-1 monoclonal antibody for treatment of agg…
Fast, Expert and Open – how the MHRA is poised to become a global leader in…
First major overhaul of medical device regulation comes into force across G…
Chikungunya vaccine (IXCHIQ) temporarily paused in people aged 65 and over …
MHRA launches new digital hub in Leeds to drive innovation and regional gro…
Helping bring phage medicines to UK patients – guidance for industry
Women on “skinny jabs” must use effective contraception, MHRA urges in late…
MHRA approves aumolertinib to treat non-small cell lung cancer
May 2025
MHRA approves polihexanide to treat acanthamoeba keratitis
First MHRA Board meeting held in Scotland, underlining agency’s commitment …
Building a faster, more effective clinical trials system
MHRA highlights “remarkable” progress and launches real-world data consulta…
MHRA approves guselkumab for Crohn’s disease and ulcerative colitis
MHRA approves vaccine to protect against pneumococcal infections such as pn…
Meet the women helping ensure that digital mental health technologies are s…
MHRA approves first UK treatment for congenital thrombotic thrombocytopenic…
MHRA approves world’s first low-carbon version of COPD inhaler Trixeo Aeros…
MHRA approves teprotumumab as the first UK treatment for adults with modera…
Vimkunya vaccine approved to prevent disease caused by the chikungunya viru…
April 2025
MHRA authorises cancer treatment variation with an administration time of 3…
Twelve arrested in MHRA’s biggest ever crackdown on organised medicines tra…
Acoramidis approved to treat wild-type or variant transthyretin amyloidosis…
Obecabtagene autoleucel conditionally approved to treat adults with relapse…
Patients with asthma reminded of the increased risk of severe asthma attack…
MHRA approves first UK treatment for Friedreich’s ataxia, omaveloxolone
Marstacimab approved to treat patients aged 12 years and above (weighing at…
Patients urged to check packs of blood pressure medicine lercanidipine afte…
Clinical Trials regulations signed into law
First-ever MHRA analysis of UK clinical trial applications finds new opport…
World Health Organization confirms MHRA to continue playing vital role in e…
Trastuzumab deruxtecan approved to treat adults with HER2-positive cancer t…
Eplontersen approved to treat adults with rare inherited nerve disease or p…
MHRA showcases next phase of regulatory science to bring innovative treatme…
Lawrence Tallon begins role as new MHRA CEO
March 2025
Dame June Raine: How innovations are transforming regulation and speeding n…
World first as MHRA approves trofolastat for diagnostic imaging of prostate…
MHRA launches new monthly safety bulletin and redesigned safety alerts
Minister visits MHRA to see cutting-edge science protecting patients and su…
New study shows MHRA collaboration with hospital DNA sequencing service cut…
Triple combination medicine deutivacaftor/tezacaftor/vanzacaftor approved f…
Lazertinib approved for use in combination with amivantamab for the treatme…
Members of the public asked to return Boots Paracetamol 500mg tablets due t…
February 2025
mRESVIA RSV vaccine approved to protect patients aged 60 and over
Nemolizumab approved to treat prurigo nodularis and atopic dermatitis (ecze…
Efanesoctocog alfa approved to prevent and treat bleeding in children and a…
Update on 2 specialist review requirements for male patients already taking…
Medical imaging agent gozetotide approved for diagnosis of prostate cancer
IXCHIQ vaccine approved to protect adults against Chikungunya
MHRA asks for views on proposed guidance to support the safe regulation of …
Digital mental health technologies guidance launched to help manufacturers …
January 2025
UK patients enabled access to transformative new medicines in shortest time…
Criminals denied £7.5m in profits from the illegal trade in medicines
Garadacimab (andembry) approved to prevent angioedema attacks
Aprocitentan approved to treat adults with hypertension whose blood pressur…
Seladelpar approved to treat adult patients in the UK with liver illness
MHRA guidance on new Medical Devices Post-Market Surveillance requirements
New MHRA Chair Anthony Harnden outlines priorities as he starts role
December 2024
Sotatercept approved to treat adult patients with pulmonary arterial hypert…
Tarlatamab approved to treat adult patients with small cell lung cancer
UK medicines regulator warns against buying weight loss medicines without a…
Givinostat conditionally approved to treat patients with Duchenne muscular …
Patients, the NHS and the Life Sciences sector set to benefit from new clin…
Medicines and medical devices: Six tips for staying healthy and safe this f…
Delgocitinib approved to treat adult patients with moderate to severe chron…
MHRA trials five innovative AI technologies as part of pilot scheme to chan…
November 2024
The MHRA issues final call to comply with Windsor Framework arrangements fo…
MHRA approves new diagnostic agent for adult patients showing signs of cogn…
Sparsentan approved to treat adult patients with primary immunoglobulin A n…
MHRA approves adapted Nuvaxovid JN.1 COVID-19 vaccine for adults and childr…
The MHRA seeks views on pre-market regulations for medical devices to impro…
MedSafetyWeek 2024: Preventing side effects
October 2024
Sugemalimab approved to treat adult patients with non-small cell lung cance…
MHRA reminds healthcare professionals to advise patients of the side effect…
World Polio Day: MHRA trains worldwide laboratories in early detection of p…
Donanemab licensed for early stages of Alzheimer’s disease in adult patient…
Statutory Instrument laid in Parliament sets out first steps in delivering …
Statutory Instrument laid in Parliament provides first regulatory framework…
Elafibranor approved to treat adults with a rare liver disease known as pri…
MHRA approves Comirnaty KP.2 COVID-19 vaccine for adults
MHRA asks patients to report without delay any safety problem with their co…
MHRA launches 2024/25 business plan with focus on enabling access to ground…
September 2024
MHRA approves first medicine for rare immune disease APDS
MHRA opens applications from AI developers to join the AI Airlock regulator…
Fruquintinib approved to treat adult patients with metastatic colorectal ca…
Application route for performance studies under the In Vitro Diagnostics Re…
MHRA launches new Strategy for Improving Safety Communications on World Pat…
MHRA advises men taking valproate and their partners to use effective contr…
MHRA finds evidence does not support a link between Glucagon-Like Peptide-1…
Medicines and medical devices: Key back-to-school tips ??
MHRA approves Spikevax JN.1 COVID-19 vaccines for adults and children from …
August 2024
Appointments of four MHRA Non-Executive Directors extended until 31 August …
Lecanemab licensed for adult patients in the early stages of Alzheimer’s di…
Zolbetuximab Approved to Treat Adults with Stomach or Gastro-oesophageal Ju…
Capivasertib approved to treat patients with advanced breast cancer
July 2024
Medicines and medical devices: Five top tips for summer?
MHRA approves Comirnaty JN.1 COVID-19 vaccine for adults and children from …
MHRA approves GLP –1 receptor agonist semaglutide to reduce risk of serious…
MHRA approves the first generic raltegravir medicines to treat adult and pa…
MHRA approves vibegron to treat adult patients with Overactive Bladder Synd…
Ocrelizumab approved as an injection to treat multiple sclerosis in adults
Man who illegally imported unlicensed medicines from India, the Middle East…
June 2024
New pregnancy prevention measures introduced for topiramate
May 2024
MHRA announces a proposed framework for international recognition of medica…
MHRA announces consultation on improved safety for high risk in vitro diagn…
MHRA announces dedicated new team to support the international community in…
Pharmacists who illegally supplied more than 55 million doses of controlled…
MHRA launches AI Airlock to address challenges for regulating medical devic…
Update on pioneering initiative on regulation and evaluation of digital men…
New cabotegravir formulations approved to help prevent HIV-1 infection in a…
April 2024
MHRA’s AI regulatory strategy ensures patient safety and industry innovatio…
Outcome of MHRA review of neuropsychiatric reactions with montelukast
Men on finasteride asked to stay vigilant for possible psychiatric and sexu…
Fosdenopterin approved to treat adult patients with molybdenum cofactor def…
Precautionary recall of some sodium chloride solutions for irrigation, eyew…
Combined antibiotic approved to treat adult patients with severe infections…
March 2024
MHRA warns of unsafe counterfeit anti-choking devices
Disgraced company director convicted of falsifying medicine quality data
Modified MAGEC X system for early onset scoliosis treatment can now be used…
MHRA response to Equity in Medical Devices: Independent Review
Quizartinib approved to treat adult patients with a type of blood cancer
Etrasimod approved to treat patients over the age of 16 with ulcerative col…
Ganaxolone approved as first anti-seizure medication to treat patients with…
Rozanolixizumab approved to treat adult patients with the autoimmune diseas…
Piflufolastat approved as diagnostic tool for adults with prostate cancer
Rubidium (Rb82) Generator approved as a diagnostic tool for people with hea…
MHRA grants first approval via the new International Recognition Procedure …
February 2024
MHRA publishes new guidance to help applicants and shorten timeframes for a…
MHRA Chief Executive Dame June Raine to step down later this year
Codeine linctus to be reclassified to a prescription-only medicine because …
Update on MHRA safety review of medicines containing pseudoephedrine
Pioneering genetic biobank to start recruiting patients on stroke preventio…
MHRA approvals for Comirnaty (Pfizer/BioNTech) and Nuvaxovid (Novavax) COVI…
January 2024
MHRA announces two new UK Approved Bodies to certify medical devices
New valproate safety measures apply from 31 January
Omjjara licensed for anaemic myelofibrosis patients to treat the symptoms o…
Illegal medicines worth more than £30 million seized in the UK in 2023
Rezzayo approved to treat adult patients with invasive candidiasis
Four-dose Mounjaro “KwikPen” approved by MHRA for diabetes and weight manag…
New safety information for omega-3-acid ethyl ester medicines (Omacor/Terom…
MHRA introduces new restrictions for fluoroquinolone antibiotics
MHRA launches new fees calculator
MHRA update on new study on risk in children born to men taking valproate
Winners of global AI cardio-health challenge announced
Regulatory Roadmap points the way ahead for new measures to support safe ac…
WHO decision improves children’s access to safer polio vaccine
MHRA’s new International Recognition Procedure (IRP) goes live from 1 Janua…
December 2023
Opdualag licensed for patients with advanced melanoma
Medicines and medical devices: 5 top tips for the festive season
Aripiprazole (Abilify): reminder on known risk of gambling disorder
Access Consortium Promise Pilot Pathway
MHRA supports launch of Innovate UK’s first-of-its-kind initiative to fund …
Manchester family locked up for illegal sale and supply of unlicensed medic…
November 2023
Precautionary action taken to amend incorrect expiry dates of flu nasal spr…
Thousands of illicit medicines seized in morning of raids in Manchester
MHRA instructs health organisations to prepare now for new measures to redu…
Specific batches of carbomer-containing lubricating eye gels branded Aacarb…
MHRA launches online Eligibility Checker tool for applications via the new …
MHRA authorises world-first gene therapy that aims to cure sickle-cell dise…
Cystic fibrosis drugs Kaftrio and Kalydeco licensed for patients aged two t…
MHRA joins global regulatory partners in celebrating ten years of internati…
MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management …
MHRA authorises enzyme inhibitor Anastrozole to prevent breast cancer in po…
Suspect you have experienced a side effect or incident from a healthcare pr…
MHRA authorises Krazati as a treatment for non-small cell lung cancer in ad…
MHRA authorises Litfulo as a treatment for severe alopecia areata in adults…
October 2023
15 years of Op Pangea: over 25 million illegally traded medicines and devic…
Treatment with isotretinoin for patients under 18 must be approved by two p…
MHRA to launch the AI-Airlock, a new regulatory sandbox for AI developers
MHRA warns of unsafe fake weight loss pens
MHRA and international partners publish five guiding principles for machine…
MHRA authorises bispecific antibody therapy Tepkinly as a treatment for dif…
Falsified Ozempic (semaglutide) pens identified at two wholesalers in the U…
New streamlined notification scheme for lowest-risk clinical trials marks s…
Safety warnings to be provided to all patients with every valproate-contain…
Patients could have faster access to ground-breaking stem cell treatment wi…
SteriFeed colostrum collector not to be used to directly feed babies due to…
MHRA pays tribute to Nobel Prize winning scientists behind mRNA COVID vacci…
MHRA authorises monoclonal antibody treatment, Jemperli, to be used with ch…
September 2023
UK patients set to have faster access to innovative medical technologies vi…
MHRA approves Moderna’s adapted COVID-19 vaccine (Spikevax) that targets Om…
Berkshire couple receive prison sentence for illegal possession and supply …
MHRA approves Pfizer/BioNTech’s adapted COVID-19 vaccine (Comirnaty) that t…
Guidance published on the new international regulatory recognition routes f…
Five people from Wolverhampton charged with illegal supply of prescription …
August 2023
Three new UK Approved Bodies to certify medical devices announced by the MH…
Polio detection times could be halved using a scientific detection method, …
Safety of valproate – new study on risks in children of men taking valproat…
MHRA reinforces anaphylaxis emergency guidance as hospital admissions rise
Bimervax COVID-19 vaccine authorised by MHRA
July 2023
MHRA launches public consultation on reclassification of opioid-containing …
Thousands of unlicensed medical products seized in morning of raids in Bolt…
MHRA puts supporting patient access to innovation at the heart of its new C…
June 2023
Timeframe for accepting CE marked medical devices in Great Britain extended
Ban lifted on use of UK plasma to manufacture life-saving albumin treatment…
New lay commissioner appointed to the Commission on Human Medicines
MHRA issues new guidance on the use of life saving adrenaline auto-injector…
Windsor Framework medicines announcement
West Midlands man sentenced to five years in prison for the illegal possess…
May 2023
SKYCovion COVID-19 vaccine authorised by MHRA
MHRA launches public consultation on ICH Good Clinical Practice Guideline w…
MHRA announces new recognition routes to facilitate safe access to new medi…
New regulatory pathway set to support safe patient access to innovative med…
Global AI challenge to investigate veterans’ cardiovascular health launched
MHRA and Genomics England to launch pioneering resource to better understan…
MHRA maintains prescription-only status of Aquiette 2.5mg Tablets for sympt…
Patients asked to return Emerade 300 and 500 microgram adrenaline pens for …
Moderna COVID-19 vaccine (Spikevax) authorised for use in infants and child…
Impact of extension of Medical Device Regulations transitional period and t…
April 2023
Medical devices – extended acceptance of CE marked medical devices on the G…
Two Non-Executive Directors reappointed to MHRA Board
Outcome of the expert review of the safety of isotretinoin
MHRA Chair Stephen Lightfoot Standing Down
New MHRA cell therapy research evaluates immune-stimulant cancer therapies …
New statutory fees for MHRA services introduced from 1 April 2023
March 2023
MHRA to streamline clinical trial approvals in biggest overhaul of trial re…
MHRA trialling pioneering stem cell robot that could transform the availabi…
MHRA to receive £10m from HM Treasury to fast-track patient access to cutti…
Safety withdrawal of pholcodine-containing cough and cold medicines
MHRA reclassifies Cialis Together tablets to a Pharmacy medicine
UK members of international criminal gang sentenced to jail for involvement…
Advisory Group Reform Proposals
February 2023
MHRA safety review of medicines containing pseudoephedrine
Second bivalent COVID-19 booster vaccine from Moderna (Spikevax) authorised…
January 2023
UK to introduce first-of-its-kind framework to make it easier to manufactur…
European Commission Decision Reliance Procedure (ECDRP) extension
MHRA increases UK assessment capacity for in-vitro diagnostic devices
Professor Tom Clutton-Brock MBE new Chair of the Interim Devices Working Gr…
December 2022
Sanofi Pasteur COVID-19 vaccine authorised by MHRA
MHRA to receive nearly £1m BEIS funding to unlock digital, data and scienti…
Life Sciences Council Joint Statement on Medical Devices Regulatory Reform
Update on MHRA review into safe use of valproate
Pfizer/BioNTech COVID-19 vaccine authorised for use in infants and children…
November 2022
Anyone with Prenoxad (naloxone) injection kits must check for missing needl…
Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK med…
Every report to MHRA’s Yellow Card scheme helps improve the safety of medic…
October 2022
Patients urged to check packs of Targocid 200mg after two batches found to …
London medicines wholesaler sentenced for illegally importing and distribut…
Unique opportunity for healthcare professionals to influence future MHRA sa…
Mental health funding of £1.8m welcomed by MHRA and NICE to explore regulat…
MHRA response to contaminated paediatric medicines identified in WHO region…
September 2022
European Commission Decision Reliance Procedure (EC DRP) extension
MHRA appoints first new UK Approved Body to certify medical devices since B…
MHRA launches new conflicts of interest code of practice for independent ad…
No change to MHRA advice on the safety and effectiveness of COVID-19 vaccin…
Pfizer/BioNTech bivalent COVID-19 booster approved by UK medicines regulato…
August 2022
Novavax COVID-19 vaccine approved for 12 to 17s by MHRA
First bivalent COVID-19 booster vaccine approved by UK medicines regulator
MHRA and CAP take action against illegal ‘hayfever jab’ adverts online
July 2022
Safety review to begin on topiramate
Over 285,000 medicines and medical devices seized UK-wide in global action
Easier access to locally-applied HRT to treat postmenopausal vaginal sympto…
June 2022
UK to strengthen regulation of medical devices to protect patients
MHRA joins international partnerships to set global standards for medicines…
May 2022
New safety warnings on risk of insulin leakage from Roche Accu-Chek Insight…
MHRA approves faricimab through international work-sharing initiative
April 2022
Share your views on making a treatment for overactive bladder available for…
MHRA approves the Moderna COVID-19 vaccine ‘Spikevax’ for use in 6 to 11-ye…
Valneva COVID-19 vaccine approved by MHRA
The MHRA are seeking views to strengthen conflicts of interest policy for i…
March 2022
Evusheld approved to prevent COVID-19 in people whose immune response is po…
Health and social care leaders unite to improve public involvement in resea…
Pharmaceutical company fined for manufacturing defective medicine
February 2022
World Cancer Day: How new partnerships are helping get breakthrough cancer …
Novavax COVID-19 vaccine Nuvaxovid approved by MHRA
Views sought on making first local vaginal HRT product available without ne…
UK’s Early Access to Medicines Scheme now to be put on a legal footing
January 2022
New proposals for the future of UK clinical trial legislation
December 2021
New Years Honour for Medicines and Healthcare products Regulatory Agency Ch…
Oral COVID-19 antiviral, Paxlovid, approved by UK regulator
Strong steroid found in ‘natural’ skin cream
UK regulator approves use of Pfizer/BioNTech vaccine in 5 to 11-year olds
MHRA's new guidance on using real-world data to support clinical trials cou…
Temporary waiver of 15-minute observation period after COVID-19 mRNA vaccin…
MHRA approves Xevudy (sotrovimab), a COVID-19 treatment found to cut hospit…
November 2021
Precautionary recall of specific batches of blood pressure drug irbesartan
MHRA statement on expansion of the COVID-19 vaccination booster programme
MHRA welcomes today’s announcement by the JCVI
Labelling error leads to retail-level recall of cold and flu medicine
First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHR…
MHRA’s new Chief Healthcare Quality and Access Officer begins important rol…
Every report counts: support the Yellow Card scheme by reporting suspected …
October 2021
MHRA publishes clear guidance to support bringing e-cigarettes to market as…
UK, USA and Canadian regulators identify 10 guiding principles to be addres…
MHRA launches public consultation on future of medical device regulation
Tesco Max All-In-One Chesty Cough & Cold Lemon Sachets are being recalled
Innovative Licensing and Access Pathway (ILAP): New partner announcement
September 2021
Transforming the regulation of software and artificial intelligence as a me…
Long-term continual use of topical steroids linked to skin withdrawal side …
MHRA statement on COVID-19 booster vaccines
MHRA statement on booster doses of Pfizer and AstraZeneca COVID-19 vaccines
Four Non-Executive Directors appointed to the Medicines and Healthcare prod…
August 2021
Batch of metformin oral solution recalled by MHRA due to nitrosamine impuri…
First monoclonal antibody treatment for COVID-19 approved for use in the UK
Moderna COVID-19 vaccine approved by MHRA in 12-17 year olds
Combined paracetamol and ibuprofen medicine approved for general sale
Regulator seeks views on innovative medicines manufacture at point of care
MHRA recalls contaminated Irbesartan- batches as precautionary measure
Access Consortium strategy launched
July 2021
Regulator warns against purchasing inaccurate infrared thermometers
MHRA’s new Chief Safety Officer, Dr Alison Cave, starts vital vigilance wor…
MHRA holds collaborative workshops with China’s medicines regulator through…
Combined review to facilitate speedier set up for clinical research trials
Pharmacists jailed for a combined total of 57 months for illegal supply of …
First progestogen-only contraceptive pills to be available to purchase from…
MHRA releases guidance in collaboration with Health Canada to improve patie…
MHRA puts delivering for patients at the heart of its Delivery Plan 2021-20…
June 2021
Prime Minister kicks off major new science initiative at visit of MHRA’s Na…
MHRA recalls contaminated Irbesartan and Losartan batches as precautionary …
Co-codamol 30/500 Effervescent Tablets recalled
Over 3 million medicines and devices seized in UK as part of global crackdo…
The MHRA concludes positive safety profile for Pfizer/BioNTech vaccine in 1…
May 2021
PT jailed for sale of steroids and unlicensed medicines online
One-dose Janssen COVID-19 vaccine approved by the MHRA
Regulator seeks views on reclassification of pain medication
UK medicines regulator issues its first authorisation under Project Orbis
MHRA announces appointment of Chief Safety Officer
April 2021
New commissioners appointed to the Commission on Human Medicines
MHRA issues new advice, concluding a possible link between COVID-19 Vaccine…
March 2021
MHRA pilots patient involvement in new applications
Five arrested following seizure of prescription-only and unlicensed medicin…
Modified COVID-19 vaccines for variants to be fast-tracked, says MHRA and o…
Pharmacist jailed for 12 months for illegal sale and supply of prescription…
February 2021
First Innovation Passport awarded to help support development and access to…
Views sought on making the oral contraceptive pill desogestrel available fr…
New partnership pledges clear and consistent evidence-based guidance on med…
Latest monitoring data confirms safety of COVID-19 vaccines
January 2021
Independent batch release testing of COVID-19 (coronavirus) vaccines by the…
Moderna vaccine becomes third COVID-19 vaccine approved by UK regulator
Access Consortium regulators pledge support to tackle COVID-19
Safety review of epilepsy medicines in pregnancy - women who may become pre…
The MHRA Innovative Licensing and Access Pathway is open for business
December 2020
Oxford University/AstraZeneca COVID-19 vaccine approved
MHRA issues exceptional use authorisation for NHS Test and Trace COVID-19 S…
June Raine: How we backed a COVID-19 vaccine before rest of the West
UK medicines regulator gives approval for first UK COVID-19 vaccine
November 2020
Oxford/AstraZeneca COVID-19 vaccine: MHRA statement confirming letter recei…
Pfizer/BioNTech COVID-19 vaccine: MHRA statement confirming data received
Pfizer/BioNTech COVID-19 vaccine: MHRA statement
Sleep disorder drug modafinil linked to increased risk of birth defects and…
Isotretinoin and suspected link with serious side effects: public and patie…
Milestone 1 million Yellow Card report for suspected side effects in #MedSa…
MHRA collaborates to disband international crime network
October 2020
Thermometer recall: Safe and Sound Infrared Ear Thermometer - MHRA urges pe…
Flublok vaccine given authorisation for temporary supply in the UK to meet …
NIBSC selected by CEPI to test coronavirus vaccines globally
UK medicines regulator joins up with Australia, Canada, Singapore and Switz…
Warfarin and other blood thinners – reminder on safe use during COVID-19 pa…
September 2020
UK regulator strengthens opioid warnings
Safety-critical alerts are changing at the MHRA
One pharmacist’s report helps safer use of inhalers in the UK
August 2020
Stephen Lightfoot to become Chair
New restrictions introduced on sales of stimulant laxatives to counter risk…
July 2020
Skin creams dried on fabric can lead to fire deaths
New synthetic datasets to assist COVID-19 and cardiovascular research
Medical Device “Certificates of Compliance” / “Attestation of Conformity” h…
MHRA response statement to IMMDS Review report publication
Don’t rely on temperature screening products for detection of coronavirus (…
June 2020
Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) …
Green light for COVID-19 trial recruitment
MHRA suspends recruitment to COVID-19 hydroxychloroquine trials
David Noakes: Judge orders seizure of £1.4 million
May 2020
Action taken to halt sales of fingerprick coronavirus (COVID-19) antibody t…
MHRA issues a scientific opinion for the first medicine to treat COVID-19 i…
Patients informed to exchange Emerade 500 micrograms adrenaline pens for a …
Applications invited for the role of Chair of the MHRA
Senior Enforcement Advisor at UK Medicines Regulator warns against purchasi…
New reagent available to support global diagnostic testing of coronavirus (…
Coronavirus: new website for reporting medicines side effects and equipment…
April 2020
MHRA approves COVID-19 vaccine trial in 7 working days
Patients informed to exchange Emerade 300 micrograms adrenaline pens for re…
Birmingham pair given suspended prison sentences for selling medicines onli…
UK medicines and medical devices regulator investigating 14 cases of fake o…
March 2020
MHRA approves new life-saving breathing aid to help keep coronavirus (COVID…
Status of Phase 1 clinical trials in response to coronavirus (COVID-19)
MHRA services during the Coronavirus (COVID-19) response
Coronavirus: global crackdown sees a rise in unlicenced medical products re…
Regulator recalls medicine used to treat myomas
Patients asked to return Emerade 150 micrograms adrenaline pens
New figures show 3.5 million unlicensed erection pills seized in 2019
February 2020
MHRA update on novel coronavirus (COVID-19)
Birmingham pharmacist jailed for trafficking Class C drugs
Taking multiple medicines? Support the Yellow Card scheme by reporting susp…
Integrated Yellow Card reporting now available in 93% of GP practices in th…
January 2020
Son of pharmacy owner sentenced for dealing wholesale medicines
Pharmacist sentenced for supplying drugs on the black market
December 2019
Metformin diabetes medicines – MHRA Update
November 2019
Strengthened recommendations for the yellow fever vaccine
MHRA drug alert: recalls for 13 over-the-counter Ranitidine medicines
Ranitidine Oral Solution and Tablets recall
October 2019
Ranitidine – MHRA drug alerts issued as Perrigo recalls prescription only a…
Welcome new MHRA senior appointments
Graeme Tunbridge appointed interim Director of Devices
Ranitidine – MHRA drug alert issued for Teva UK recall
Life Sciences and UK's future role: Sir John Bell delivers MHRA annual lect…
Zantac – MHRA drug alert issued as GlaxoSmithKline recalls all unexpired st…
Emerade pens – patients reminded to carry 2 pens at all times
September 2019
Contact lenses recall: 1-day Acuvue Moist for Astigmatism - MHRA urges pati…
Supply problems with total parenteral nutrition (TPN) bags – Calea UK site …
Welcome interim Chief Executive Dr June Raine
Two benzoyl peroxide products to treat mild acne affecting the face to go o…
Update on the licensing status of Avastin when intended for intravitreal ad…
Biological medicine quality to receive major boost
MHRA and the Bill & Melinda Gates Foundation to look at the safer, effectiv…
August 2019
HRT users to discuss risks and benefits at next appointment as new study hi…
Dr June Raine to become interim Chief Executive Officer
First allergy test for hair dye to go on general sale
Sussex criminal sentenced for laundering proceeds from the sale of black-ma…
July 2019
Patients to check if they have certain prescription-only medicines as addit…
East London crook charged with meds crimes
MHRA launches consultation on how to best engage patients and the public
June 2019
Patients to check if they have prescription-only medicines being recalled
Non-Executive Directors to join Agency
March 2019
Three further batches of blood pressure and heart medication recalled from …
Medical Device Alert issued for urogynaecological mesh manufactured by C.R.…
February 2019
Peppino Fiori: repeat offender subject to confiscation order
Assets liquidated – an unhappy Valentine for Teesside crook
Medicine mailing man sentenced for illicit supply
Opioid Expert Working Group meets at MHRA
Additional blood pressure and heart medication recalled from pharmacies
Organised crime update: Dangerous Diazepam diversion down by 73%
January 2019
UK and Russia sign MoU on Regulatory Cooperation on Medicines
Alert to users of FreeStyle Libre flash glucose monitoring system regarding…
MHRA recalls more blood pressure and heart medication from pharmacies as a …
West London crooks convicted of conspiracy to supply illicit meds
Irbesartan blood pressure and heart medication recalled from pharmacies by …
MHRA releases response to consultation on EU exit no-deal legislative propo…
December 2018
Herbal skin cream found to contain steroids
Emollient cream build-up in fabric can lead to fire deaths
Teething gels for babies and children to be sold in pharmacies only
November 2018
MHRA recalls Valsartan blood pressure and heart medication from pharmacies
Notorious Noakes, £10m Guernsey GcMAF crook imprisoned
Agency CEO to step down in September 2019
Help make medicines safer: report suspected side effects in children and du…
October 2018
We need to think differently on cancer to save even more lives says Sir Har…
UK seizes more than £2 million of fake medicines as part of international c…
Regulator seizes almost 10,000 unsafe STI + HIV test kits
UK and Indian authorities clamp down on international medicines crime
Roche CoaguChek device producing inaccurate results
Digital pregnancy tests recalled in new alert amid false positive results
MHRA to consult on EU exit no-deal legislative proposals
Drug reaction reporting scheme now more accessible to healthcare profession…
September 2018
BIA and MHRA publish report ‘Collaborative Working in the UK, Driving Innov…
Improving how we collect and document consent
Voluntary recall of USA-manufactured homeopathic products: check for affect…
The Family-run Fake Pill Factory: trio busted following drugs raid
Poster from the Independent Medicines and Medical Devices Safety Review
Change in the classification of certain glucosamine products
Welcome to our new MHRA website
August 2018
Persistent peddler jailed for dealing dodgy sex drugs
July 2018
Batches of Durex condoms recalled: people urged to check their batch number…